TOP >
News Release
> list in 2010
- 2010.08.27
- Notice of Daiichi Sankyo Organizational Restructuring to be Effective October 1, 2010
- 2010.08.25
- Daiichi Sankyo Files for Approval to Manufacture and Market AMG 162 (Denosumab) in Japan
- 2010.08.03
- ARQULE AND DAIICHI SANKYO MOVE FORWARD WITH PHASE 3 CLINICAL TRIAL PLAN FOR ARQ 197 IN NON-SMALL CELL LUNG CANCER
- 2010.07.30
-
Announcement Regarding the Establishment of a Joint Venture Company between Daiichi Sankyo and The Kitasato Institute
- 2010.07.30
- Daiichi Sankyo to Issue Stock Options (Stock Acquisition Rights) as Remuneration
- 2010.07.27
- FDA APPROVES TRIBENZOR™, A NEW THREE-IN-ONE COMBINATION PRODUCT FOR THE TREATMENT OF HIGH BLOOD PRESSURE
- 2010.07.21
- Daiichi Sankyo to Leverage Ranbaxy's Network to Market Its Innovative Antibiotic Tavanic® (Levofloxacin) in Romania and South Africa
- 2010.07.12
- EDOXABAN DEMONSTRATES SUPERIOR EFFICACY COMPARED WITH ENOXAPARIN SODIUM IN PREVENTING VTE AFTER TOTAL KNEE REPLACEMENT
- 2010.07.02
- Daiichi Sankyo and Ranbaxy to Integrate New Drug Research and Development System
- 2010.06.14
- The Japan Research Foundation for Clinical Pharmacology, A Daiichi Sankyo Foundation, has awarded Third Annual Clinical Pharmacology Research Award
- 2010.06.07
- ARQULE AND DAIICHI SANKYO PRESENT FINAL PHASE 2 RESULTS FOR ARQ 197 C-MET INHIBITOR IN NON-SMALL CELL LUNG CANCER AT ASCO
- 2010.04.16
- Daiichi Sankyo Receives Launches Rezaltas(R) Combination Tablets to Treat Hypertension
- 2010.04.06
- DAIICHI SANKYO SUBMITS FIRST NEW DRUG APPLICATION FOR ORAL FACTOR Xa INHIBITOR, EDOXABAN
- 2010.03.12
- Daiichi Sankyo Announces Second Mid-term Business Management Plan (FY 2010-2012)
- 2010.03.05
- Daiichi Sankyo to join the National Cherry Blossom Festival in Washington D.C. to celebrate the 100-year anniversary of the gift of cherry blossom trees from Japan
- 2010.02.26
- Daiichi Sankyo Group to Expand its Business Scope in Japan through Establishment of Daiichi Sankyo Espha Co., Ltd.
- 2010.02.15
- FDA Approves Benicar(R) for the Treatment of High Blood Pressure in Children and Adolescents aged 6-16(1)
- 2010.02.10
-
Daiichi Sankyo to Launch Innovator Products in Mexico through Ranbaxy
Companies to Fully Leverage the Synergistic Power of the Hybrid Business Model
- 2010.02.08
- Announcement of Approval Application in Japan for Manufacturing and Marketing of SUN Y7017 (Memantine) for the Treatment of Alzheimer's Type Dementia
- 2010.02.03
- DAIICHI SANKYO INITIATES LARGEST SINGLE, DOUBLE-BLIND,RANDOMIZED, PHASE 3 TRIAL FOR TREATMENT AND PREVENTION OF RECURRENT VENOUS THROMBOEMBOLISM
- 2010.02.01
- Daiichi Sankyo Submits a New Drug Application in Japan for CS-8958, a Long-Acting Neuraminidase Inhibitor for the Treatment of Influenza
- 2010.01.20
- Daiichi Sankyo Receives Approval to Manufacture and Market Rezaltas(R) Combination Tablets to Treat Hypertension
